Log in
Create new account
home
boards
job center
archives
company monitor
cp wire
device news
pharmagather
advertise
contact us
Home
analysts
Cancer Drug Developer NewLink Genetics Gets Push From Analysts
Cancer Drug Developer NewLink Genetics Gets Push From Analysts
Minyanville
analysts
NewLink Genetics
pancreatic cancer
Will Biogen Idec Disappoint Analysts Next Quarter?
Will Biogen Idec Disappoint Analysts Next Quarter?
Motley Fool
analysts
Biogen Idec
Analysts see an upside after market swings bludgeon biotechs
Analysts see an upside after market swings bludgeon biotechs
Fierce Biotech
analysts
biotech
Teva Analysts Stick to ‘Buy’ Ratings as Stock Repays Love With 41% Decline
Teva Analysts Stick to ‘Buy’ Ratings as Stock Repays Love With 41% Decline
Bloomberg
analysts
Teva Pharmaceuticals
Analyst ratings boost drug stocks
Analyst ratings boost drug stocks
Marketwatch
analysts
BioSante
biotech
GTx
Regeneron
News
Analysts say new RFP makes SIGA likely winner of gov't smallpox-drug contract; shares leap
Yahoo/AP
analysts
government contracts
SIGA
News
Sanofi-Genzyme: What the Analysts Are Saying
Seeking Alpha
analysts
Genzyme
M&A
Sanofi
News
Analysts Welcome Change at Pfizer’s Helm but Want More
Seeking Alpha
analysts
Ian Read
Pfizer
News
GlaxoSmithKline - Upgrades & Downgrades
TheStreet.com
analysts
downgrades
GSK
upgrades
»
2 comments
News
Sanofi Likely to Shell out More for Genzyme: Analysts
CNBC
analysts
Genzyme
hostile takeover
M&A
Sanofi
»
2 comments
1
2
next ›
last »
news tags
Abbott Laboratories
Amgen
Arena Pharmaceuticals
AstraZeneca
Bayer
Biogen Idec
biotech
Boston Scientific
Bristol-Myers Squibb
cancer
Celgene
China
Dendreon
diabetes
earnings
Eli Lilly
Europe
FDA
generics
Genzyme
GSK
hepatitis C
investors
JNJ
lawsuits
layoffs
M&A
Management
Medtronic
Merck
Novartis
obesity
patents
Pfizer
prostate cancer
Roche
Sanofi
Teva Pharmaceuticals
vaccines
Vivus
more tags
Yahoo! Finance
Quote for ABT